We reasoned that, if citrullination acts by revealing previously cryptic epitopes to induce loss of tolerance, CD4+ T cells from RA patients with anti-citrulline immune responses (i.e., ACPAs) would preferentially respond to the citrullination-dependent peptide repertoire. This evidence concerns the gene CD4 and rheumatoid arthritis.